Ferronova Secures A$11 Million to Advance Nanotech Image-guided Cancer Therapy
Ferronova CEO Stewart Bartlett said raising capital in a challenging environment and winning a CRC-P grant was a credit to the strength of Ferronova’s technology.
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Ferronova Secures A$11 Million to Advance Nanotech Image-guided Cancer Therapy
Ferronova CEO Stewart Bartlett said raising capital in a challenging environment and winning a CRC-P grant was a credit to the strength of Ferronova’s technology.